Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Biagioni

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Biomedicines|August 28, 2025
Targeting CEACAM5: Biomarker Characterization and Fluorescent Probe Labeling for Image-Guided Gastric Cancer SurgerySerena Martinelli, Sara Peri, Cecilia Anceschi, et al.
Ebiomedicine|January 7, 2019
EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cellsAnna Laurenzana, Francesca Margheri, Alessio Biagioni, et al.
Cancer Letters|January 15, 2019
Cell-targeted c(AmpRGD)-sunitinib molecular conjugates impair tumor growth of melanomaFrancesca Bianchini, Elisabetta Portioli, Francesca Ferlenghi, et al.
Antioxidants (Basel, Switzerland)|September 23, 2022
An Oleocanthal-Enriched EVO Oil Extract Induces the ROS Production in Gastric Cancer Cells and Potentiates the Effect of ChemotherapySara Peri, Jessica Ruzzolini, Silvia Urciuoli, et al.
International Journal of Cancer|June 4, 2017
uPA/uPAR system activation drives a glycolytic phenotype in melanoma cellsAnna Laurenzana, Anastasia Chillà, Cristina Luciani, et al.
Frontiers in Oncology|May 31, 2021
CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell LinesAlessio Biagioni, Anastasia Chillà, Mario Del Rosso, et al.
Cancers|September 10, 2021
Glutamine Availability Controls BCR/Abl Protein Expression and Functional Phenotype of Chronic Myeloid Leukemia Cells Endowed with Stem/Progenitor Cell PotentialMartina Poteti, Giulio Menegazzi, Silvia Peppicelli, et al.
Cancers|October 27, 2022
miR-214-Enriched Extracellular Vesicles Released by Acid-Adapted Melanoma Cells Promote Inflammatory Macrophage-Dependent Tumor Trans-Endothelial MigrationElena Andreucci, Jessica Ruzzolini, Francesca Bianchini, et al.
Oncotarget|July 9, 2014
Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzymeAnna Laurenzana, Alessio Biagioni, Silvia D'Alessio, et al.
Oncology Research|July 28, 2021
uPAR Controls Vasculogenic Mimicry Ability Expressed by Drug-Resistant Melanoma CellsElena Andreucci, Anna Laurenzana, Silvia Peppicelli, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Biomedicines|August 28, 2025
Targeting CEACAM5: Biomarker Characterization and Fluorescent Probe Labeling for Image-Guided Gastric Cancer SurgerySerena Martinelli, Sara Peri, Cecilia Anceschi, et al.
Ebiomedicine|January 7, 2019
EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cellsAnna Laurenzana, Francesca Margheri, Alessio Biagioni, et al.
Cancer Letters|January 15, 2019
Cell-targeted c(AmpRGD)-sunitinib molecular conjugates impair tumor growth of melanomaFrancesca Bianchini, Elisabetta Portioli, Francesca Ferlenghi, et al.
Antioxidants (Basel, Switzerland)|September 23, 2022
An Oleocanthal-Enriched EVO Oil Extract Induces the ROS Production in Gastric Cancer Cells and Potentiates the Effect of ChemotherapySara Peri, Jessica Ruzzolini, Silvia Urciuoli, et al.
International Journal of Cancer|June 4, 2017
uPA/uPAR system activation drives a glycolytic phenotype in melanoma cellsAnna Laurenzana, Anastasia Chillà, Cristina Luciani, et al.
Frontiers in Oncology|May 31, 2021
CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell LinesAlessio Biagioni, Anastasia Chillà, Mario Del Rosso, et al.
Cancers|September 10, 2021
Glutamine Availability Controls BCR/Abl Protein Expression and Functional Phenotype of Chronic Myeloid Leukemia Cells Endowed with Stem/Progenitor Cell PotentialMartina Poteti, Giulio Menegazzi, Silvia Peppicelli, et al.
Cancers|October 27, 2022
miR-214-Enriched Extracellular Vesicles Released by Acid-Adapted Melanoma Cells Promote Inflammatory Macrophage-Dependent Tumor Trans-Endothelial MigrationElena Andreucci, Jessica Ruzzolini, Francesca Bianchini, et al.
Oncotarget|July 9, 2014
Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzymeAnna Laurenzana, Alessio Biagioni, Silvia D'Alessio, et al.
Oncology Research|July 28, 2021
uPAR Controls Vasculogenic Mimicry Ability Expressed by Drug-Resistant Melanoma CellsElena Andreucci, Anna Laurenzana, Silvia Peppicelli, et al.
Pageof 6